(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Tempest Therapeutics, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Wednesday, December 31st, 2025 | 2024 | Stephen Brady Chief Executive Officer and President | 600,000 | 0 | 0 | 280,500 | 13,800 | 1,872,299 |
| Wednesday, December 31st, 2025 | 2024 | Stephen Brady Chief Executive Officer and President | 600,000 | 0 | 0 | 280,500 | 13,800 | 1,872,299 |
| Wednesday, December 31st, 2025 | 2024 | Nicholas Maestas Chief Financial Officer | 365,547 | 0 | 0 | 100,068 | 0 | 622,095 |
| Wednesday, December 31st, 2025 | 2023 | Nicholas Maestas Chief Financial Officer | 351,488 | 0 | 0 | 113,355 | 586 | 1,319,038 |
| Wednesday, December 31st, 2025 | 2023 | Nicholas Maestas Chief Financial Officer | 351,488 | 0 | 0 | 113,355 | 586 | 1,319,038 |
| Wednesday, December 31st, 2025 | 2023 | Stephen Brady Chief Executive Officer and President | 567,000 | 0 | 0 | 343,035 | 13,200 | 7,007,407 |
| Wednesday, December 31st, 2025 | 2023 | Stephen Brady Chief Executive Officer and President | 567,000 | 0 | 0 | 343,035 | 13,200 | 7,007,407 |
| Wednesday, December 31st, 2025 | 2024 | Samuel Whiting Chief Medical Officer | 481,749 | 0 | 0 | 175,838 | 13,800 | 1,062,587 |
| Wednesday, December 31st, 2025 | 2024 | Samuel Whiting Chief Medical Officer | 481,749 | 0 | 0 | 175,838 | 13,800 | 1,062,587 |
| Wednesday, December 31st, 2025 | 2023 | Samuel Whiting Chief Medical Officer | 454,480 | 0 | 0 | 199,971 | 13,200 | 3,384,949 |
| Wednesday, December 31st, 2025 | 2023 | Samuel Whiting Chief Medical Officer | 454,480 | 0 | 0 | 199,971 | 13,200 | 3,384,949 |
| Wednesday, December 31st, 2025 | 2024 | Nicholas Maestas Chief Financial Officer | 365,547 | 0 | 0 | 100,068 | 0 | 622,095 |
| Tuesday, April 23rd, 2024 | 2022 | Stephen Brady Chief Executive Officer and President | 530,000 | 0 | 0 | 198,750 | 12,200 | 1,514,366 |
| Tuesday, April 23rd, 2024 | 2023 | Stephen Brady Chief Executive Officer and President | 567,000 | 0 | 0 | 343,035 | 13,200 | 7,007,407 |
| Tuesday, April 23rd, 2024 | 2023 | Stephen Brady Chief Executive Officer and President | 567,000 | 0 | 0 | 343,035 | 13,200 | 7,007,407 |
| Tuesday, April 23rd, 2024 | 2023 | Nicholas Maestas Chief Financial Officer | 351,488 | 0 | 0 | 113,355 | 586 | 1,319,038 |
| Tuesday, April 23rd, 2024 | 2023 | Nicholas Maestas Chief Financial Officer | 351,488 | 0 | 0 | 113,355 | 586 | 1,319,038 |
| Tuesday, April 23rd, 2024 | 2022 | Samuel Whiting Chief Medical Officer | 437,000 | 0 | 0 | 142,025 | 12,200 | 833,398 |
| Tuesday, April 23rd, 2024 | 2022 | Samuel Whiting Chief Medical Officer | 437,000 | 0 | 0 | 142,025 | 12,200 | 833,398 |
| Tuesday, April 23rd, 2024 | 2023 | Samuel Whiting Chief Medical Officer | 454,480 | 0 | 0 | 199,971 | 13,200 | 3,384,949 |
| Tuesday, April 23rd, 2024 | 2023 | Samuel Whiting Chief Medical Officer | 454,480 | 0 | 0 | 199,971 | 13,200 | 3,384,949 |
| Tuesday, April 23rd, 2024 | 2022 | Stephen Brady Chief Executive Officer and President | 530,000 | 0 | 0 | 198,750 | 12,200 | 1,514,366 |
| Monday, May 1st, 2023 | 2022 | Samuel Whiting Chief Medical Officer | 437,000 | 0 | 0 | 142,025 | 12,200 | 833,398 |
| Monday, May 1st, 2023 | 2021 | Thomas Dubensky President | 475,283 | 0 | 0 | 190,113 | 272,677 | 1,500,167 |
| Monday, May 1st, 2023 | 2021 | Thomas Dubensky President | 475,283 | 0 | 0 | 190,113 | 272,677 | 1,500,167 |
| Monday, May 1st, 2023 | 2022 | Thomas Dubensky President | 489,541 | 0 | 0 | 183,578 | 12,200 | 1,100,586 |
| Monday, May 1st, 2023 | 2021 | Samuel Whiting Chief Medical Officer | 400,000 | 0 | 0 | 140,000 | 0 | 836,737 |
| Monday, May 1st, 2023 | 2022 | Stephen Brady Chief Executive Officer | 530,000 | 0 | 0 | 198,750 | 12,200 | 1,514,366 |
| Monday, May 1st, 2023 | 2022 | Stephen Brady Chief Executive Officer | 530,000 | 0 | 0 | 198,750 | 12,200 | 1,514,366 |
| Monday, May 1st, 2023 | 2022 | Thomas Dubensky President | 489,541 | 0 | 0 | 183,578 | 12,200 | 1,100,586 |
| Monday, May 1st, 2023 | 2021 | Stephen Brady Chief Executive Officer | 475,283 | 0 | 0 | 190,113 | 0 | 714,721 |
| Monday, May 1st, 2023 | 2021 | Stephen Brady Chief Executive Officer | 475,283 | 0 | 0 | 190,113 | 0 | 714,721 |
| Monday, May 1st, 2023 | 2021 | Samuel Whiting Chief Medical Officer | 400,000 | 0 | 0 | 140,000 | 0 | 836,737 |
| Monday, May 1st, 2023 | 2022 | Samuel Whiting Chief Medical Officer | 437,000 | 0 | 0 | 142,025 | 12,200 | 833,398 |
| Monday, May 2nd, 2022 | 2021 | Louis Arcudi III Former Chief Executive Officer | 211,694 | 880,000 | 0 | 0 | 0 | 1,632,960 |
| Monday, May 2nd, 2022 | 2021 | Louis Arcudi III Former Chief Executive Officer | 211,694 | 880,000 | 0 | 0 | 0 | 1,632,960 |
| Monday, May 2nd, 2022 | 2020 | Julia C. Owens Former Chief Executive Officer | 526,300 | 0 | 0 | 263,150 | 8,550 | 2,281,928 |
| Monday, May 2nd, 2022 | 2020 | Julia C. Owens Former Chief Executive Officer | 526,300 | 0 | 0 | 263,150 | 8,550 | 2,281,928 |
| Monday, May 2nd, 2022 | 2021 | Julia C. Owens Former Chief Executive Officer | 120,415 | 0 | 0 | 0 | 1,184,175 | 1,339,793 |
| Monday, May 2nd, 2022 | 2021 | Julia C. Owens Former Chief Executive Officer | 120,415 | 0 | 0 | 0 | 1,184,175 | 1,339,793 |
| Monday, May 2nd, 2022 | 2021 | Thomas Dubensky President | 475,283 | 0 | 0 | 190,113 | 272,677 | 1,500,167 |
| Monday, May 2nd, 2022 | 2021 | Thomas Dubensky President | 475,283 | 0 | 0 | 190,113 | 272,677 | 1,500,167 |
| Monday, May 2nd, 2022 | 2021 | Samuel Whiting Chief Medical Officer | 400,000 | 0 | 0 | 140,000 | 0 | 836,737 |
| Monday, May 2nd, 2022 | 2021 | Samuel Whiting Chief Medical Officer | 400,000 | 0 | 0 | 140,000 | 0 | 836,737 |
| Monday, May 2nd, 2022 | 2021 | Stephen Brady Chief Executive Officer | 475,283 | 0 | 0 | 190,113 | 0 | 714,721 |
| Monday, May 2nd, 2022 | 2021 | Stephen Brady Chief Executive Officer | 475,283 | 0 | 0 | 190,113 | 0 | 714,721 |
| Monday, May 2nd, 2022 | 2020 | Louis Arcudi III Former Chief Executive Officer | 378,400 | 0 | 0 | 151,360 | 8,550 | 976,240 |
| Monday, May 2nd, 2022 | 2020 | Louis Arcudi III Former Chief Executive Officer | 378,400 | 0 | 0 | 151,360 | 8,550 | 976,240 |
| Friday, April 24th, 2020 | 2019 | Ryan Zeidan | 320,625 | 40,000 | 0 | 106,566 | 44,494 | 849,145 |
| Friday, April 24th, 2020 | 2019 | Ryan Zeidan | 320,625 | 40,000 | 0 | 106,566 | 44,494 | 849,145 |
| Friday, April 24th, 2020 | 2019 | Louis Arcudi Former Chief Executive Officer | 350,000 | 0 | 0 | 126,000 | 19,792 | 1,003,401 |
| Friday, April 24th, 2020 | 2019 | Louis Arcudi Former Chief Executive Officer | 350,000 | 0 | 0 | 126,000 | 19,792 | 1,003,401 |
| Friday, April 24th, 2020 | 2019 | Julia C. Owens Chief Executive Officer | 478,900 | 0 | 0 | 215,505 | 8,400 | 2,381,882 |
| Friday, April 24th, 2020 | 2019 | Julia C. Owens Chief Executive Officer | 478,900 | 0 | 0 | 215,505 | 8,400 | 2,381,882 |
| Friday, April 24th, 2020 | 2018 | Julia C. Owens Chief Executive Officer | 432,600 | 50,000 | 0 | 179,529 | 8,250 | 2,424,207 |
| Friday, April 24th, 2020 | 2018 | Julia C. Owens Chief Executive Officer | 432,600 | 50,000 | 0 | 179,529 | 8,250 | 2,424,207 |
| Monday, April 29th, 2019 | 2017 | Julia C. Owens Chief Executive Officer | 420,000 | 83,160 | 0 | 84,840 | 8,100 | 596,100 |
| Monday, April 29th, 2019 | 2018 | Julia C. Owens Chief Executive Officer | 432,600 | 50,000 | 0 | 179,529 | 8,250 | 2,424,207 |
| Monday, April 29th, 2019 | 2018 | Julia C. Owens Chief Executive Officer | 432,600 | 50,000 | 0 | 179,529 | 8,250 | 2,424,207 |
| Monday, April 29th, 2019 | 2017 | Christopher Kroeger, M.D., M.B.A Former Chief Executive Officer | 292,127 | 131,457 | 0 | 0 | 16,424 | 2,430,088 |
| Monday, April 29th, 2019 | 2017 | Christopher Kroeger, M.D., M.B.A Former Chief Executive Officer | 292,127 | 131,457 | 0 | 0 | 16,424 | 2,430,088 |
| Monday, April 29th, 2019 | 2017 | Pharis Mohideen Chief Medical Officer | 356,895 | 49,466 | 0 | 50,465 | 25,064 | 481,890 |
| Monday, April 29th, 2019 | 2018 | Christopher Kroeger, M.D., M.B.A Former Chief Executive Officer | 513,836 | 330,000 | 0 | 0 | 810,594 | 2,058,163 |
| Monday, April 29th, 2019 | 2018 | Jeffery M. Brinza | 308,117 | 16,000 | 0 | 89,508 | 8,250 | 869,661 |
| Monday, April 29th, 2019 | 2017 | Pharis Mohideen Chief Medical Officer | 356,895 | 49,466 | 0 | 50,465 | 25,064 | 481,890 |
| Monday, April 29th, 2019 | 2018 | Jeffery M. Brinza | 308,117 | 16,000 | 0 | 89,508 | 8,250 | 869,661 |
| Monday, April 29th, 2019 | 2018 | Christopher Kroeger, M.D., M.B.A Former Chief Executive Officer | 513,836 | 330,000 | 0 | 0 | 810,594 | 2,058,163 |
| Monday, April 29th, 2019 | 2017 | Jonathan Gillis, C.P.A. Former Senior Vice President, Finance | 229,008 | 187,500 | 0 | 0 | 8,977 | 476,978 |
| Monday, April 29th, 2019 | 2017 | Jonathan Gillis, C.P.A. Former Senior Vice President, Finance | 229,008 | 187,500 | 0 | 0 | 8,977 | 476,978 |
| Monday, April 29th, 2019 | 2018 | Jonathan Gillis, C.P.A. Former Senior Vice President, Finance | 252,247 | 94,500 | 0 | 0 | 203,783 | 654,783 |
| Monday, April 29th, 2019 | 2018 | Jonathan Gillis, C.P.A. Former Senior Vice President, Finance | 252,247 | 94,500 | 0 | 0 | 203,783 | 654,783 |
| Monday, April 29th, 2019 | 2018 | Pharis Mohideen Chief Medical Officer | 367,602 | 0 | 0 | 106,788 | 35,021 | 919,881 |
| Monday, April 29th, 2019 | 2018 | Pharis Mohideen Chief Medical Officer | 367,602 | 0 | 0 | 106,788 | 35,021 | 919,881 |
| Monday, April 29th, 2019 | 2017 | Julia C. Owens Chief Executive Officer | 420,000 | 83,160 | 0 | 84,840 | 8,100 | 596,100 |
| Monday, April 30th, 2018 | 2017 | Christophe Couturier Former Chief Financial Officer | 243,945 | 155,000 | 0 | 0 | 11,163 | 585,206 |
| Monday, April 30th, 2018 | 2017 | Christophe Couturier Former Chief Financial Officer | 243,945 | 155,000 | 0 | 0 | 11,163 | 585,206 |
| Monday, April 30th, 2018 | 2017 | Christopher Kroeger, M.D., M.B.A. | 292,127 | 131,457 | 0 | 0 | 16,424 | 2,430,088 |
| Monday, April 30th, 2018 | 2017 | Christopher Kroeger, M.D., M.B.A. | 292,127 | 131,457 | 0 | 0 | 16,424 | 2,430,088 |
| Monday, April 30th, 2018 | 2017 | Michelle Dipp, M.D., Ph.D. Former Chief Executive Officer and Executive Chair | 334,247 | 75,000 | 0 | 0 | 248,714 | 1,017,386 |
| Monday, April 30th, 2018 | 2017 | Michelle Dipp, M.D., Ph.D. Former Chief Executive Officer and Executive Chair | 334,247 | 75,000 | 0 | 0 | 248,714 | 1,017,386 |
| Monday, April 30th, 2018 | 2016 | Michelle Dipp, M.D., Ph.D. Former Chief Executive Officer and Executive Chair | 478,846 | 333,000 | 0 | 0 | 18,566 | 860,412 |
| Monday, April 30th, 2018 | 2016 | Michelle Dipp, M.D., Ph.D. Former Chief Executive Officer and Executive Chair | 478,846 | 333,000 | 0 | 0 | 18,566 | 860,412 |
| Monday, April 30th, 2018 | 2015 | Michelle Dipp, M.D., Ph.D. Former Chief Executive Officer and Executive Chair | 0 | 0 | 435,794 | 0 | 0 | 435,794 |
| Monday, April 30th, 2018 | 2015 | Michelle Dipp, M.D., Ph.D. Former Chief Executive Officer and Executive Chair | 0 | 0 | 435,794 | 0 | 0 | 435,794 |
| Monday, April 30th, 2018 | 2016 | Christophe Couturier Former Chief Financial Officer | 113,846 | 139,200 | 357,500 | 0 | 7,014 | 1,652,612 |
| Monday, April 30th, 2018 | 2016 | Christophe Couturier Former Chief Financial Officer | 113,846 | 139,200 | 357,500 | 0 | 7,014 | 1,652,612 |
| Monday, April 30th, 2018 | 2017 | Jonathan Gillis, C.P.A. Former Senior Vice President, Finance | 229,008 | 187,500 | 0 | 0 | 8,977 | 476,978 |
| Monday, April 30th, 2018 | 2017 | Jonathan Gillis, C.P.A. Former Senior Vice President, Finance | 229,008 | 187,500 | 0 | 0 | 8,977 | 476,978 |
| Wednesday, April 26th, 2017 | 2016 | Paul Chapman | 351,442 | 75,000 | 0 | 0 | 320,949 | 2,460,372 |
| Wednesday, April 26th, 2017 | 2014 | Michelle Dipp, M.D., Ph.D. Executive Chair | 0 | 0 | 1,280,444 | 0 | 0 | 5,629,030 |
| Wednesday, April 26th, 2017 | 2014 | Michelle Dipp, M.D., Ph.D. Executive Chair | 0 | 0 | 1,280,444 | 0 | 0 | 5,629,030 |
| Wednesday, April 26th, 2017 | 2015 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 422,692 | 127,500 | 183,938 | 0 | 13,459 | 747,589 |
| Wednesday, April 26th, 2017 | 2015 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 422,692 | 127,500 | 183,938 | 0 | 13,459 | 747,589 |
| Wednesday, April 26th, 2017 | 2016 | Michelle Dipp, M.D., Ph.D. Executive Chair | 478,846 | 333,000 | 0 | 0 | 18,566 | 830,412 |
| Wednesday, April 26th, 2017 | 2016 | Michelle Dipp, M.D., Ph.D. Executive Chair | 478,846 | 333,000 | 0 | 0 | 18,566 | 830,412 |
| Wednesday, April 26th, 2017 | 2015 | Michelle Dipp, M.D., Ph.D. Executive Chair | 0 | 0 | 435,794 | 0 | 0 | 435,794 |
| Wednesday, April 26th, 2017 | 2015 | Jeffrey E. Young Former Chief Financial Officer | 308,500 | 114,000 | 367,875 | 0 | 7,973 | 798,348 |
| Wednesday, April 26th, 2017 | 2015 | Jeffrey E. Young Former Chief Financial Officer | 308,500 | 114,000 | 367,875 | 0 | 7,973 | 798,348 |
| Wednesday, April 26th, 2017 | 2016 | Harald Stock, Ph.D.. | 627,446 | 200,000 | 2,355,000 | 0 | 952,384 | 5,746,218 |
| Wednesday, April 26th, 2017 | 2016 | Paul Chapman | 351,442 | 75,000 | 0 | 0 | 320,949 | 2,460,372 |
| Wednesday, April 26th, 2017 | 2015 | Michelle Dipp, M.D., Ph.D. Executive Chair | 0 | 0 | 435,794 | 0 | 0 | 435,794 |
| Wednesday, April 26th, 2017 | 2016 | Christophe Couturier Former Chief Financial Officer | 113,846 | 139,200 | 357,500 | 0 | 7,014 | 1,652,612 |
| Wednesday, April 26th, 2017 | 2016 | Christophe Couturier Former Chief Financial Officer | 113,846 | 139,200 | 357,500 | 0 | 7,014 | 1,652,612 |
| Wednesday, April 26th, 2017 | 2016 | Jeffrey E. Young Former Chief Financial Officer | 299,616 | 0 | 0 | 0 | 378,063 | 677,679 |
| Wednesday, April 26th, 2017 | 2016 | Jeffrey E. Young Former Chief Financial Officer | 299,616 | 0 | 0 | 0 | 378,063 | 677,679 |
| Wednesday, April 26th, 2017 | 2014 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 350,000 | 294,000 | 0 | 0 | 13,258 | 4,164,930 |
| Wednesday, April 26th, 2017 | 2014 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 350,000 | 294,000 | 0 | 0 | 13,258 | 4,164,930 |
| Wednesday, April 26th, 2017 | 2016 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 120,962 | 0 | 0 | 0 | 328,916 | 449,878 |
| Wednesday, April 26th, 2017 | 2016 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 120,962 | 0 | 0 | 0 | 328,916 | 449,878 |
| Wednesday, April 26th, 2017 | 2016 | Harald Stock, Ph.D.. | 627,446 | 200,000 | 2,355,000 | 0 | 952,384 | 5,746,218 |
| Monday, April 18th, 2016 | 2015 | Theresa McNeely | 283,056 | 0 | 0 | 0 | 30,982 | 314,038 |
| Monday, April 18th, 2016 | 2014 | David Harding Former Chief Commercial | 12,696 | 8,400 | 0 | 0 | 761 | 4,477,995 |
| Monday, April 18th, 2016 | 2014 | David Harding Former Chief Commercial | 12,696 | 8,400 | 0 | 0 | 761 | 4,477,995 |
| Monday, April 18th, 2016 | 2013 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 106,346 | 0 | 0 | 0 | 504 | 4,352,579 |
| Monday, April 18th, 2016 | 2013 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 106,346 | 0 | 0 | 0 | 504 | 4,352,579 |
| Monday, April 18th, 2016 | 2015 | Jeffrey E. Young Former Chief Financial Officer | 308,500 | 114,000 | 367,875 | 0 | 7,973 | 798,348 |
| Monday, April 18th, 2016 | 2015 | Jeffrey E. Young Former Chief Financial Officer | 308,500 | 114,000 | 367,875 | 0 | 7,973 | 798,348 |
| Monday, April 18th, 2016 | 2013 | Michelle Dipp, M.D., Ph.D. Executive Chair and Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Monday, April 18th, 2016 | 2013 | Michelle Dipp, M.D., Ph.D. Executive Chair and Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Monday, April 18th, 2016 | 2015 | David Harding Former Chief Commercial | 242,308 | 80,000 | 0 | 0 | 89,560 | 411,868 |
| Monday, April 18th, 2016 | 2015 | David Harding Former Chief Commercial | 242,308 | 80,000 | 0 | 0 | 89,560 | 411,868 |
| Monday, April 18th, 2016 | 2014 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 350,000 | 294,000 | 0 | 0 | 13,258 | 4,164,930 |
| Monday, April 18th, 2016 | 2014 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 350,000 | 294,000 | 0 | 0 | 13,258 | 4,164,930 |
| Monday, April 18th, 2016 | 2015 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 422,692 | 127,500 | 183,938 | 0 | 13,459 | 747,589 |
| Monday, April 18th, 2016 | 2015 | Arthur Tzianabos, Ph.D. Former President and Chief Scientific Officer | 422,692 | 127,500 | 183,938 | 0 | 13,459 | 747,589 |
| Monday, April 18th, 2016 | 2014 | Michelle Dipp, M.D., Ph.D. Executive Chair and Chief Executive Officer | 0 | 0 | 1,280,444 | 0 | 0 | 5,629,030 |
| Monday, April 18th, 2016 | 2014 | Michelle Dipp, M.D., Ph.D. Executive Chair and Chief Executive Officer | 0 | 0 | 1,280,444 | 0 | 0 | 5,629,030 |
| Monday, April 18th, 2016 | 2015 | Michelle Dipp, M.D., Ph.D. Executive Chair and Chief Executive Officer | 0 | 0 | 435,794 | 0 | 0 | 435,794 |
| Monday, April 18th, 2016 | 2015 | Michelle Dipp, M.D., Ph.D. Executive Chair and Chief Executive Officer | 0 | 0 | 435,794 | 0 | 0 | 435,794 |
| Monday, April 18th, 2016 | 2015 | Theresa McNeely | 283,056 | 0 | 0 | 0 | 30,982 | 314,038 |
| Monday, April 20th, 2015 | 2013 | Arthur Tzianabos, Ph.D. President and Chief Scientific | 106,346 | 0 | 0 | 0 | 504 | 4,352,579 |
| Monday, April 20th, 2015 | 2013 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Monday, April 20th, 2015 | 2014 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 1,280,444 | 0 | 0 | 5,629,030 |
| Monday, April 20th, 2015 | 2014 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 1,280,444 | 0 | 0 | 5,629,030 |
| Monday, April 20th, 2015 | 2013 | Arthur Tzianabos, Ph.D. President and Chief Scientific | 106,346 | 0 | 0 | 0 | 504 | 4,352,579 |
| Monday, April 20th, 2015 | 2013 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Monday, April 20th, 2015 | 2014 | David Harding Former Chief Commercial | 12,696 | 8,400 | 0 | 0 | 761 | 4,477,995 |
| Monday, April 20th, 2015 | 2014 | David Harding Former Chief Commercial | 12,696 | 8,400 | 0 | 0 | 761 | 4,477,995 |
| Monday, April 20th, 2015 | 2014 | Arthur Tzianabos, Ph.D. President and Chief Scientific | 350,000 | 294,000 | 0 | 0 | 13,258 | 4,164,930 |
| Monday, April 20th, 2015 | 2014 | Arthur Tzianabos, Ph.D. President and Chief Scientific | 350,000 | 294,000 | 0 | 0 | 13,258 | 4,164,930 |
| Wednesday, April 30th, 2014 | 2012 | Arthur Tzianabos, Ph.D. Chief Scientific Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2013 | Arthur Tzianabos, Ph.D. Chief Scientific Officer | 106,346 | 0 | 0 | 0 | 504 | 4,352,579 |
| Wednesday, April 30th, 2014 | 2013 | Arthur Tzianabos, Ph.D. Chief Scientific Officer | 106,346 | 0 | 0 | 0 | 504 | 4,352,579 |
| Wednesday, April 30th, 2014 | 2013 | Alison Lawton Former Chief Operating Officer | 323,077 | 0 | 0 | 0 | 10,163 | 5,001,402 |
| Wednesday, April 30th, 2014 | 2012 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 1,500,000 | 0 | 0 | 3,442,618 |
| Wednesday, April 30th, 2014 | 2013 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2013 | Alison Lawton Former Chief Operating Officer | 323,077 | 0 | 0 | 0 | 10,163 | 5,001,402 |
| Wednesday, April 30th, 2014 | 2012 | Alison Lawton Former Chief Operating Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2012 | Alison Lawton Former Chief Operating Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2012 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 1,500,000 | 0 | 0 | 3,442,618 |
| Wednesday, April 30th, 2014 | 2013 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 30th, 2014 | 2012 | Arthur Tzianabos, Ph.D. Chief Scientific Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, April 26th, 2013 | 2012 | Scott Chappel, Ph.D. Chief Scientific Officer | 300,000 | 108,000 | 0 | 0 | 16,158 | 424,158 |
| Friday, April 26th, 2013 | 2011 | Christopher Bleck Chief Commercial Officer | 27,692 | 0 | 0 | 0 | 0 | 283,645 |
| Friday, April 26th, 2013 | 2011 | Christopher Bleck Chief Commercial Officer | 27,692 | 0 | 0 | 0 | 0 | 283,645 |
| Friday, April 26th, 2013 | 2012 | Christopher Bleck Chief Commercial Officer | 240,000 | 70,000 | 0 | 0 | 10,890 | 619,221 |
| Friday, April 26th, 2013 | 2012 | Christopher Bleck Chief Commercial Officer | 240,000 | 70,000 | 0 | 0 | 10,890 | 619,221 |
| Friday, April 26th, 2013 | 2011 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 1,420 | 0 | 0 | 1,420 |
| Friday, April 26th, 2013 | 2011 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 1,420 | 0 | 0 | 1,420 |
| Friday, April 26th, 2013 | 2012 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 1,500,000 | 0 | 0 | 3,442,618 |
| Friday, April 26th, 2013 | 2012 | Michelle Dipp, M.D., Ph.D. Chief Executive Officer | 0 | 0 | 1,500,000 | 0 | 0 | 3,442,618 |
| Friday, April 26th, 2013 | 2011 | Scott Chappel, Ph.D. Chief Scientific Officer | 136,157 | 129,462 | 0 | 0 | 248 | 480,869 |
| Friday, April 26th, 2013 | 2011 | Scott Chappel, Ph.D. Chief Scientific Officer | 136,157 | 129,462 | 0 | 0 | 248 | 480,869 |
| Friday, April 26th, 2013 | 2012 | Scott Chappel, Ph.D. Chief Scientific Officer | 300,000 | 108,000 | 0 | 0 | 16,158 | 424,158 |
